A Mendelian randomization showed that higher kidney injury molecule-1 reduced the likelihood of hospitalization by searching the association of cardiometabolic risk factors with COVID-19 severity.[79] Inadequately, endogenous factors are more favorable as biomarkers than therapeutics. The gene discussed is HAVCR1; the disease is COVID-19.